ArticleFrontiers in medicine2026

Effect of curcumin combined with vedolizumab on disease activity in patients with moderate to severe ulcerative colitis and its correlation with inflammatory and immune factors.

Ye Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.